BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35794096)

  • 1. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.
    Burkhardt B; Michgehl U; Rohde J; Erdmann T; Berning P; Reutter K; Rohde M; Borkhardt A; Burmeister T; Dave S; Tzankov A; Dugas M; Sandmann S; Fend F; Finger J; Mueller S; Gökbuget N; Haferlach T; Kern W; Hartmann W; Klapper W; Oschlies I; Richter J; Kontny U; Lutz M; Maecker-Kolhoff B; Ott G; Rosenwald A; Siebert R; von Stackelberg A; Strahm B; Woessmann W; Zimmermann M; Zapukhlyak M; Grau M; Lenz G
    Nat Commun; 2022 Jul; 13(1):3881. PubMed ID: 35794096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
    Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
    Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic and endemic Burkitt lymphoma have frequent
    Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
    Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of mutations in Burkitt lymphoma.
    Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
    Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
    Wever CM; Geoffrion D; Grande BM; Yu S; Alcaide M; Lemaire M; Riazalhosseini Y; Hébert J; Gavino C; Vinh DC; Petrogiannis-Haliotis T; Dmitrienko S; Mann KK; Morin RD; Johnson NA
    Leuk Lymphoma; 2018 Sep; 59(9):2159-2174. PubMed ID: 29295643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.
    Thomas N; Dreval K; Gerhard DS; Hilton LK; Abramson JS; Ambinder RF; Barta S; Bartlett NL; Bethony J; Bhatia K; Bowen J; Bryan AC; Cesarman E; Casper C; Chadburn A; Cruz M; Dittmer DP; Dyer MA; Farinha P; Gastier-Foster JM; Gerrie AS; Grande BM; Greiner T; Griner NB; Gross TG; Harris NL; Irvin JD; Jaffe ES; Henry D; Huppi R; Leal FE; Lee MS; Martin JP; Martin MR; Mbulaiteye SM; Mitsuyasu R; Morris V; Mullighan CG; Mungall AJ; Mungall K; Mutyaba I; Nokta M; Namirembe C; Noy A; Ogwang MD; Omoding A; Orem J; Ott G; Petrello H; Pittaluga S; Phelan JD; Ramos JC; Ratner L; Reynolds SJ; Rubinstein PG; Sissolak G; Slack G; Soudi S; Swerdlow SH; Traverse-Glehen A; Wilson WH; Wong J; Yarchoan R; ZenKlusen JC; Marra MA; Staudt LM; Scott DW; Morin RD
    Blood; 2023 Feb; 141(8):904-916. PubMed ID: 36201743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
    Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
    Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T
    Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
    Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
    Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
    Simbolo M; Vicentini C; Ruzzenente A; Brunelli M; Conci S; Fassan M; Mafficini A; Rusev B; Corbo V; Capelli P; Bria E; Pedron S; Turri G; Lawlor RT; Tortora G; Bassi C; Guglielmi A; Scarpa A
    Sci Rep; 2018 May; 8(1):7119. PubMed ID: 29740198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic differences between paediatric and adult Burkitt lymphomas.
    Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
    Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
    Rohde M; Richter J; Schlesner M; Betts MJ; Claviez A; Bonn BR; Zimmermann M; Damm-Welk C; Russell RB; Borkhardt A; Eils R; Hoell JI; Szczepanowski M; Oschlies I; Klapper W; Burkhardt B; Siebert R; ;
    Genes Chromosomes Cancer; 2014 Nov; 53(11):911-6. PubMed ID: 25044415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
    Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I
    Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.